Immunolocalization of Wilms' Tumor protein (WT1) in developing human peripheral sympathetic and gastroenteric nervous system

Acta Histochemica

Volumn 116, Issue 1, 2014, Pages 48-54

  Parenti, Rosalba ^a   Puzzo, Lidia ^b   Vecchio, Giada Maria ^b   Gravina, Lucia ^a   Salvatorelli, Lucia ^b   Musumeci, Giuseppe ^a   Vasquez, Enrico ^b   Magro, Gaetano ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cytoplasmic immunostaining; Human fetus; Immunohistochemistry; Sympathetic peripheral nervous system; Wilms' tumor gene; WT1

Indexed keywords

WT1 PROTEIN; WT1 PROTEIN, HUMAN;

ANTIBODY SPECIFICITY; CHROMAFFIN CELL; EMBRYOLOGY; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INNERVATION; METABOLISM; NEURAL STEM CELL; SYMPATHETIC NERVE CELL;

CHROMAFFIN CELLS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEURAL STEM CELLS; ORGAN SPECIFICITY; SYMPATHETIC FIBERS, POSTGANGLIONIC; WT1 PROTEINS;

EID: 84894899543     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.05.003     Document Type: Article

References (63)

1. Armstrong J.F., Pritchard-Jones K., Bickmore W.A., Hastie N.D., Bard J.B. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 1993, 40:85-97.
2. Becanovic K., Pouladi M.A., Lim R.S., Kuhn A., Pavlidis P., Luthi-Carter R., et al. Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum Mol Genet 2010, 19:1438-1452.
3. Bisceglia M., Galliani C., Lastilla G., Rosai J. TTF-1 and WT1 expression in embryonal soft tissue, visceral, and central nervous system tumors. An immunohistochemical study of 100 cases. Pathologica 2010, 102:253-254.
4. Bisceglia M., Vairo M., Galliani C., Lastilla G., Parafioriti A., DeMaglio G., et al. Immunohistochemical investigation of WT1 expression in 117 embryonal tumors. Pathologica 2011, 103:182-183.
5. Bourne T.D., Elias W.J., Lopes M.B., Mandell J.W. WT1 is not a reliable marker to distinguish reactive from neoplastic astrocyte populations in the central nervous system. Brain Pathol 2010, 20:1090-1095.
6. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003, 3:203-216.
7. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60:509-520.
8. Carpentieri D.F., Nichols K., Chou P.M., Matthews M., Pawel B., Huff D. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol 2002, 15:1080-1086.
9. Charles A.K., Mall S., Watson J., Berry P.J. Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mol Pathol 1997, 50:138-144.
10. Cooper M.J., Hutchins G.M., Mennie R.J., Israel M.A. β2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation. Cancer Res 1990, 50:3694-3700.
11. Cooper M.J., Hutchins G.M., Cohen P.S. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ 1990, 1:149-159.
12. Coupland R.E. The natural history of the chromaffin cell - twenty-five years on the beginning. Arch Histol Cytol 1989, 52(Suppl.):331-341.
13. De Preter K., Vandesompele J., Heimann P., Yigit N., Beckman S., Schramm A., et al. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 2007, 8:401.
14. Dennis S.L., Manji S.S., Carrington D.P., Scarcella D.L., Ashley D.M., Smith P.J., et al. Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors. Int J Cancer 2002, 10(97):713-715.
15. Ellisen L.W. Regulation of gene expression by WT1 in development and tumorigenesis. Int J Hematol 2002, 76:110-116.
16. Fraternali-Orcioni G., Ravetti J.L., Gaggero G., Bocca B., Bisceglia M. Primary embryonal spindle cell cardiac rhabdomyosarcoma: case report. Pathol Res Pract 2010, 206:325-330.
17. Gershon M.D., Chalazonitis A., Rothman T.P. From neural crest to bowel: development of the enteric nervous system. J Neurobiol 1993, 24:199-214.
18. Gessler M., Poustka A., Cavenee W., Neve R.L., Orkin S.H., Burns G.A. Homozygous deletion in Wilms' tumors of a zinc-finger gene identified by chromosome jumping. Nature (Lond.) 1990, 343:774-778.
19. Goji J., Nakamura H., Ito H., Mabuchi O., Hashimoto K., Sano K. Expression of c-ErbB2 in human neuroblastoma tissues, adrenal medulla adjacent to tumor, and developing mouse neural crest cells. Am J Pathol 1995, 146:660-672.
20. Hartkamp J., Roberts S.G. The role of the Wilms' tumour-suppressor protein WT1 in apoptosis. Biochem Soc Trans 2008, 36:629-631.
21. Hedborg F., Ohlsson R., Sandstedt B., Grimelius L., Hoehner J.C., Pählman S. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 1995, 146:833-847.
22. Hoehner J.C., Gestblom C., Hedborg F., Sandstedt B., Olsen L., Påhlman S. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest 1996, 75:659-675.
23. Hoehner J.C., Hedborg F., Eriksson L., Sandstedt B., Grimelius L., Olsen L., et al. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab Invest 1998, 78:29-45.
24. Hohenstein P., Hastie N.D. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 2006, 15(Spec No. 2):R196-R201.
25. Hoshi N., Sugino T., Suzuki T. Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells. Med Mol Morphol 2009, 42:110-117.
26. Huff V. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 2011, 11:111-121.
27. Inagaki T., Fukuda T., Ohta A., Hano H. No oncogenic role for WT1 in peripheral nerve sheath tumors. Jikeikai Med J 2011, 58:95-102.
28. Joshy V.V., Silverman J.F. Pathology of neuroblastic tumors. Semin Diagn Pathol 1994, 11:107-111.
29. Krajewski S., Chatten J., Hanada M., Reed J.C. Immunohistochemical analysis of the bcl-2 oncoprotein in human neuroblastomas. Comparison with tumor cell differentiation and N-myc protein. Lab Invest 1995, 71:42-54.
30. Lee S.B., Haber D.A. Wilms tumor and the WT1 gene. Exp Cell Res 2001, 264(March (1)):74-99.
31. Lovell M.A., Xie C., Xiong S., Markesbery W.R. Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Brain Res 2003, 983:84-96.
32. Magro G., Grasso S., Emmanuele C. Immunohistochemical distribution of S-100 protein and type IV collagen in human embryonic and fetal sympathetic neuroblasts. Histochem J 1995, 27:694-701.
33. Magro G., Grasso S. Immunohistochemical identification and comparison of glial cell lineage in foetal, neonatal, adult and neoplastic human adrenal medulla. Histochem J 1997, 29:293-299.
34. Magro G., Grasso S. The glial cell in the ontogenesis of the human peripheral sympathetic nervous system and in neuroblastoma. Pathologica 2001, 93:505-516.
35. Magro G., Ruggieri M., Fraggetta F., Grasso S., Viale G. Cathepsin D is a marker of ganglion cell differentiation in the developing and neoplastic human peripheral sympathetic nervous tissues. Virchows Arch 2000, 437:406-412.
36. Magro G., Cataldo I., Amico P., Torrisi A., Vecchio G.M., Parenti R., et al. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid 2011, 21:267-277.
37. Menke A.L., van der Eb A.J., Jochemsen A.G. The Wilms' tumor 1 gene: oncogene or tumor suppressor gene?. Int Rev Cytol 1998, 181:151-212.
38. Mohlin S., Hamidian A., Påhlman S. HIF2A and IGF2 expression correlates in human neuroblastoma cells and normal immature sympathetic neuroblasts. Neoplasia 2013, 15:328-334.
39. Molenaar W.M., Lee V.M., Trojanowski J.Q. Early fetal acquisition of the chromaffin and neuronal immunophenotype by human adrenal medullary cells. An immunohistological study using monoclonal antibodies to chromogranin A, synaptophysin, tyrosine hydroxylase, and neuronal cytoskeletal proteins. Exp Neurol 1990, 108:1-9.
40. Mundlos S., Pelletier J., Darveau A., Bachmann M., Winterpacht A., Zabel B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 1993, 119:1329-1341.
41. Nakahara Y., Okamoto H., Mineta T., Tabuchi K. Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas. Brain Tumor Pathol 2004, 21:113-116.
42. Nakatsuka S., Oji Y., Horiuchi T., Kanda T., Kitagawa M., Takeuchi T., et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 2006, 19:804-814.
43. Niksic M., Slight J., Sanford J.R., Caceres J.F., Hastie N.D. The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 2004, 13(4).
44. Oji Y., Suzuki T., Nakano Y., Maruno M., Nakatsuka S., Jomgeow T., et al. Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors. Cancer Sci. 2004, 95:822-827.
45. Oue T., Uehara S., Yamanaka H., Takama Y., Oji Y., Fukuzawa M. Expression of Wilms tumor 1 gene in a variety of pediatric tumors. J Pediatr Surg 2011, 46:2233-2238.
46. Parenti R., Perris R., Vecchio G.M., Salvatorelli L., Torrisi A., Gravina L., et al. Immunohistochemical expression of Wilms' tumor protein (WT1) in developing human epithelial and mesenchymal tissues. Acta Histochem 2013, 115:70-75.
47. Pritchard-Jones K., Fleming S., Davidson E.C., Bickmore W., Porteus D.J., Gosden C., et al. The candidate Wilms' tumor gene is involved in genitourinary development. Nature (Lond.) 1990, 346:194-197.
48. Rackley R.R., Flenniken A.M., Kuriyan N.P., Kessler P.M., Stoler M.H., Williams B.R. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth Differ 1993, 4:1023-1031.
49. Ramani P., Cowell J.K. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. J Pathol 1996, 179:162-168.
50. Roberts S.G. The modulation of WTI transcription function by cofactors. Biochem Soc Symp 2006, 73:191-201.
51. Salvatorelli L., Bisceglia M., Vecchio G., Parenti R., Galliani C., Alaggio R., et al. A comparative immunohistochemical study of oncofetal cytoplasmic WT1 expression in human fetal, adult and neoplastic skeletal muscle. Pathologica 2011, 103:186.
52. Schittenhelm J., Beschorner R., Simon P., Tabatabai G., Herrmann C., Schlaszus H., et al. Diagnostic value of WT1 in neuroepithelial tumours. Neuropathol Appl Neurobiol 2009, 35:69-81.
53. Schittenhelm J., Thiericke J., Nagel C., Meyermann R., Beschorner R. WT1 expression in normal and neoplastic cranial and peripheral nerves is independent of grade of malignancy. Cancer Biomark 2010, 7:73-77.
54. Scholz H., Kirschner K.M. A role for the Wilms' tumor protein WT1 in organ development. Physiology (Bethesda) 2005, 20:54-59.
55. Sharma P.M., Yang X., Bowman M., Roberts V., Sukumar S. Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res 1992, 52:6407-6412.
56. Trindade F., Tellechea O., Torrelo A., Requena L., Colmenero I. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol 2011, 33:569-572.
57. Trojanowski J.Q., Molenaar W.M., Baker D.L., Pleasure D., Lee V.M. Neural and neuroendocrine phenotype of neuroblastomas, ganglioneuroblastomas, ganglioneuromas and mature versus embryonic human adrenal medullary cell. Adv Neuroblastoma Res 1991, 3:335-341.
58. Wagner K.D., Wagner N., Bondke A., Nafz B., Flemming B., Theres H., et al. The Wilms' tumor suppressor WT1 is expressed in the coronary vasculature after myocardial infarction. FASEB J 2002, 16:1117-1119.
59. Wagner K.D., Wagner N., Vidal V.P.I., Schley G., Wilhelm D., Schedl A., et al. The Wilms' tumor gene WT1 is required for normal development of the retina. EMBO J 2002, 21:1398-1405.
60. Wagner N., Wagner K.D., Theres H., Englert C., Schedl A., Scholz H. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor WT1. Genes Dev 2005, 19:2631-2642.
61. Wagner N., Wagner K.D., Hammes A., Kirschner K.M., Vidal V.P., Schedl A., et al. A splice variant of the Wilms' tumour suppressor WT1 is required for normal development of the olfactory system. Development 2005, 132:1327-1336.
62. Wagner N., Michiels J.F., Schedl A., Wagner K.D. The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo. Oncogene 2008, 27:3662-3672.
63. Wang J., Oue T., Uehara S., Yamanaka H., Oji Y., Fukuzawa M. The role of WT1 gene in neuroblastoma. J Pediatr Surg 2011, 46:326-331.